Clinical Trials Directory

Trials / Completed

CompletedNCT00804440

Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions

A Randomized, Single-Dose, Two-Way Crossover Relative Bioavailability Study of Ibuprofen Tablet Formulations in Fasted Normal, Healthy Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Perrigo Company · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Compare the rate and extent of absorption of two oral formulations of Ibuprofen 800 mg Tablets, administered as a single, one-tablet dose in fasted subjects.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofen Tablets, 800 mg

Timeline

Start date
2004-01-01
Primary completion
2004-01-01
First posted
2008-12-08
Last updated
2012-03-16

Source: ClinicalTrials.gov record NCT00804440. Inclusion in this directory is not an endorsement.